Efficacy and safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in ovarian cancer: a systematic review of current evidence.
Fiche publication
Date publication
juin 2024
Journal
Archives of gynecology and obstetrics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr AKLADIOS Chérif
Tous les auteurs :
Pavone M, Jochum F, Lecointre L, Bizzarri N, Taliento C, Restaino S, Vizzielli G, Fagotti A, Scambia G, Querleu D, Akladios C
Lien Pubmed
Résumé
PIPAC is a recent approach for intraperitoneal chemotherapy with promising results for patients with peritoneal carcinomatosis. A systematic review was conducted to assess current evidence on the efficacy and outcomes of PIPAC in patients affected by ovarian cancer.
Mots clés
Ovarian cancer, PIPAC, Peritoneal carcinomatosis, Pressurized intraperitoneal aerosol chemotherapy
Référence
Arch Gynecol Obstet. 2024 06 15;: